Frontlight ResearchEarly access
Trial site
H-T.Centrum Medyczne Sp. z o.o.
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis4 trials
- Crohn's disease3 trials
- Phase
- Phase 24 trials
- Phase 33 trials
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Lead sponsor
- AbbVie3 trials
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)2 trials
- Celgene International II S.a.r.l.1 trial
- Landos Biopharma Inc.1 trial
Running trials
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
Active, not recruiting
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Closed trials
Completed
Completed
Completed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026